STANDARD DOSE 131I THERAPY FOR HYPERTHYROIDISM CAUSED BY AUTONOMOUSLY FUNCTIONING THYROID NODULES
- 1 January 1979
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 10 (1) , 69-77
- https://doi.org/10.1111/j.1365-2265.1979.tb03035.x
Abstract
SUMMARY: Thirty‐one patients with hyperthyroidism shown on scintigram to have autonomously functioning thyroid nodules were treated with a standard dose of 15 milli‐curies (mCi) of 131I. Of thirty patients who have been followed up for at least 6 months to over 3 years, all but one patient were euthyroid after a single dose. Repeat scintigram and Thyrotropin Releasing Hormone (TRH) test after therapy confirmed that twenty‐five patients were cured of the disease. Only one patient developed hypothyroidism. This simplified standard dose regimen of radioiodine is effective in the treatment of hyperthyroidism caused by autonomously functioning nodules and is not complicated by the high incidence of hypothyroidism that is observed following radioiodine therapy of Graves’disease.Keywords
This publication has 13 references indexed in Scilit:
- INTENTIONAL RADIOIODINE ABLATION IN GRAVES' DISEASEThe Lancet, 1975
- Plummer's DiseaseMedical Clinics of North America, 1975
- Solitary autonomously functioning thyroid lesionsThe American Journal of Medicine, 1975
- THYROID FUNCTION IN EUTHYROID SUBJECTS WITH AUTONOMOUS THYROID NODULESClinical Endocrinology, 1974
- Treatment of diffuse toxic goiter with 131ISeminars in Nuclear Medicine, 1971
- The Scintillation Camera with Pinhole Collimator in Thyroid ImagingRadiology, 1971
- Complications of radioiodine treatment of hyperthyroidismSeminars in Nuclear Medicine, 1971
- Scintigraphic evaluation of nodular goiterSeminars in Nuclear Medicine, 1971
- THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TESTThe Lancet, 1971
- Radioiodine in Diagnosis and Therapy of HyperthyroidismArchives of internal medicine (1960), 1962